4-氯-4`-甲基苯丁酮 | 38425-26-2

• 物质功能分类: 化学试剂 - 有机试剂 - 芳香酮
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-氯-4`-甲基苯丁酮
• 中文别名: 4-氯-4-甲基苯丁酮
• 英文名称: 4-chloro-1-(4-methylphenyl)butan-1-one
• 英文别名: 4-chloro-1-(p-tolyl)butan-1-one；4-Chloro-4'-methylbutyrophenone
• CAS: 38425-26-2
• 化学式: C₁₁H₁₃ClO
• 分子量: 196.677
• InChiKey: FUHGFUBJUUFMSF-UHFFFAOYSA-N

物化性质

• 熔点：
  31.5 °C
• 沸点：
  282.19°C (rough estimate)
• 密度：
  1.0753 (rough estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2914700090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P233,P260,P261,P264,P270,P271,P280,P301+P310,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
• 危险品运输编号：
  2811
• 危险性描述：
  H301,H315,H319,H335,H317
• 储存条件：
  存放在阴凉干燥处即可。

SDS

Name:	4-Chloro-4 -methylbutyrophenone 95% Material Safety Data Sheet
Synonym:	4-Chloro-1-(4-methylphenyl)-1-butanon
CAS:	38425-26-2

Section 1 - Chemical Product MSDS Name:4-Chloro-4 -methylbutyrophenone 95% Material Safety Data Sheet
Synonym:4-Chloro-1-(4-methylphenyl)-1-butanon

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
38425-26-2	4-Chloro-4'-methylbutyrophenone, 95%	95%	253-924-3

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. No information found.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Wash hands before eating. Use with adequate ventilation. Avoid breathing dust, vapor, mist, or gas.
Avoid contact with skin and eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Good general ventilation should be sufficient to control airborne levels.
Exposure Limits CAS# 38425-26-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: orange-brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 31.5 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H13ClO
Molecular Weight: 196.68

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 38425-26-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-4'-methylbutyrophenone, 95% - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 38425-26-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 38425-26-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 38425-26-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氯-4`-甲基苯丁酮 在 sodium azide 、 三苯基膦 作用下， 以 二甲基亚砜 、 正戊烷 为溶剂， 反应 26.0h， 生成 5-(p-tolyl)-3,4-dihydro-2H-pyrrole
  参考文献：
  名称：

  Synthesis of 3-halopyrroles

  摘要：

  DOI：

  10.1016/s0040-4020(97)00092-6
• 作为产物：
  描述：

  1-(p-tolyl)cyclobutan-1-ol 在 manganese(II) triflate 、 四丁基醋酸铵 、 溶剂黄146 、 magnesium chloride 作用下， 以 乙腈 为溶剂， 反应 3.5h， 以76%的产率得到4-氯-4`-甲基苯丁酮
  参考文献：
  名称：

  锰催化的烷氧基自由基对环烷醇的电化学解构氯化反应。

  摘要：

  已经开发了锰催化的环烷醇的电化学解构氯化法。这种电化学方法可从醇中获得烷氧基，并具有广泛的底物范围，可将各种环丙醇和环丁醇转化为可合成使用的β-和γ-氯化酮（40个实例）。此外，采用循环流电化学和连续在线纯化的组合以克为单位获得产物。

  DOI：

  10.1021/acs.orglett.9b03652

文献信息

• Intermediates useful for the preparation of antihistaminic piperidine derivatives
  申请人：Merrell Pharmaceuticals, Inc.

  公开号：US06348597B2

  公开（公告）日：2002-02-19

  The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula wherein W represents —C(═O)— or —CH(OH)—; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.

  本发明涉及一种新型中间体和过程，该中间体和过程在制备某些抗组胺酸哌啶衍生物的过程中非常有用，其化学式为 其中 W代表—C(═O)—或—CH(OH)—; R1代表氢或羟基; R2代表氢; R1和R2一起形成连接R1和R2的碳原子之间的第二键; n为1至5的整数; m为0或1的整数; R3为—COOH或—COO烷基，其中烷基基团具有1至6个碳原子，直链或支链，A的每个是氢或羟基;以及其药用可接受盐和各自的光学异构体， 但是当R1和R2一起形成连接R1和R2的碳原子之间的第二键或当R1代表羟基时，m为0。
• Substituted heterocycle fused gamma-carbolines
  申请人：——

  公开号：US20040220178A1

  公开（公告）日：2004-11-04

  The present invention is directed to methods of treating addictive behavior and sleep disorders by administering compounds represented by structural Formula (I) 1 or pharmaceutically acceptable salt forms thereof, wherein R 1 , R 5 , R 6a , R 6b , R 7 , R 8 , R 9 , X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.

  本发明涉及通过给予由结构式（I）表示的化合物或其药学上可接受的盐形式来治疗成瘾行为和睡眠障碍的方法，其中R1、R5、R6a、R6b、R7、R8、R9、X、b、k、m和n以及虚线如本文所述。本发明治疗方法中使用的化合物是5-羟色胺激动剂和拮抗剂，对于控制或预防包括成瘾行为和睡眠障碍在内的中枢神经系统疾病是有用的。
• [EN] Process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl-propanenitrile<br/>[FR] PROCÉDÉ POUR LA PRODUCTION DE 2-[4-(CYCLOPROPANECARBONYL)PHÉNYL]-2-MÉTHYL-PROPANENITRILE
  申请人：SANOFI AVENTIS DEUTSCHLAND

  公开号：WO2016116555A1

  公开（公告）日：2016-07-28

  A new process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl- propanenitrile is described. This compound can be used for the production of drugs, such as Fexofenadine.

  描述了一种生产2-[4-(环丙基甲酰基)苯基]-2-甲基丙腈的新工艺。这种化合物可用于生产药物，如非索非丁。
• Very short highly enantioselective Grignard synthesis of 2,2-disubstituted tetrahydrofurans and tetrahydropyrans
  作者：Claudio Monasterolo、Helge Müller-Bunz、Declan G. Gilheany

  DOI：10.1039/c9sc00978g

  日期：——

  synthesis of tertiary alcohols. In turn this enables the simple, short and highly enantioselective (up to 96% ee) preparation of chiral 2,2-disubstituted THFs and THPs. Thus, asymmetric addition of Grignard reagents to γ-chlorobutyrophenones and δ-chlorovalerophenones takes place in the presence of a chiral diaminocyclohexyl-derived tridentate ligand and subsequent base-promoted intramolecular cyclisation

  具有细长链的苯酚是配体促进的不对称格利雅（Grignard）叔醇合成的优良底物。反过来，这可以实现简单，短暂和高度对映选择性（ee高达96％）制备手性2,2-二取代的THF和THP。因此，在存在手性二氨基环己基衍生的三齿配体的情况下，将格氏试剂不对称地添加到γ-氯代丁酮和δ-氯代戊烯酮中，随后发生碱基促进的分子内环化反应，并完全保留了不对称性。作为方法学的例子，我们报道了棉酚，γ-乙基-γ-苯基丁内酯和δ-甲基-δ-甲苯基戊内酯的最短合成，波维尼安A的联合最短且灵活的合成以及波维尼安B和yingzhaosu的最短形式合成C。
• Synthesis of Nitrogenated Heterocycles by Asymmetric Transfer Hydrogenation of <i>N</i>-(<i>tert</i>-Butylsulfinyl)haloimines
  作者：Óscar Pablo、David Guijarro、Miguel Yus

  DOI：10.1021/jo4014386

  日期：2013.9.20

  Highly optically enriched, protected, nitrogenated heterocycles with different ring sizes have been synthesized by a very efficient methodology consisting of the asymmetric transfer hydrogenation of N-(tert-butylsulfinyl)haloimines followed by treatment with a base to promote an intramolecular nucleophilic substitution process. N-Protected aziridines, pyrrolidines, piperidines, and azepanes bearing

  已经通过非常有效的方法合成了具有不同环尺寸的高度光学富集，受保护的氮化杂环，该方法包括N-（叔丁基亚磺酰基）卤代胺的不对称转移氢化，然后用碱处理以促进分子内亲核取代过程。ñ-已经获得了具有芳香族，杂芳香族和脂肪族取代基的保护的氮丙啶，吡咯烷，哌啶和氮杂环丙烷，它们的收率非常高，非对映体比例高达> 99：1。游离的杂环可通过简单而温和的脱亚磺酰化方法容易地获得。通过改变亚磺酰基基团的硫原子的绝对构型，可以制备具有相同良好结果的游离杂环的两种对映异构体。